Lowe, Price, LeBlanc & Becker
5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinyl benzimidazole derivatives
 The present invention relates to a novel compound 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivative having the following formula (I): ##STR1## or a pharmaceutically acceptable salt thereof, in which X represents S, SO or SO.sub.2, PA0 Y represents halogen, PA0 R.sub.1 and R.sub.2 independently from each other represent hydrogen or methyl, PA0 R.sub.3 represents hydrogen, C.sub.1 -C.sub.8 alkyl, --SR.sub.6, --N(R.sub.7).sub.2, or a group of formula --OR.sub.6 or --O(CH.sub.2).sub.m --Z, wherein PA0 R.sub.6 represents C.sub.1 -C.sub.4 alkyl, C.sub.2 -C.sub.4 alkenyl, C.sub.3 -C.sub.10 cycloalkyl optionally substituted with C.sub.1 -C.sub.4 alkyl, C.sub.2 -C.sub.5 fluoroalkyl, phenyl optionally substituted with C.sub.1 -C.sub.4 alkyl or benzyl optionally substituted with C.sub.1 -C.sub.4 alkyl, PA0 R.sub.7 represents hydrogen or C.sub.1 -C.sub.5 alkyl, PA0 Z represents a group of formula --O(CH.sub.2).sub.q --R.sub.9 wherein PA0 q denotes an integer of 1 to 3, and R.sub.9 represents hydrogen, PA0 m represents an integer of 2 to 10, and 
Il-Yang Pharm. Co., Ltd.
C A
C07D A61P
inventional inventional
Sang H. Sung J. Sung K. Dong Y. Su U. Seung M. Gi J.
Nam Park Hong Kim Kim Lee Chung